Adamas to present at upcoming william blair biotech focus conference

Emeryville, calif.--(business wire)--adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that neil f. mcfarlane, chief executive officer, will participate in a fireside chat at the william blair biotech focus conference 2021 on thursday, july 15, 2021 at 1:00 pm eastern time. the fireside chat will be broadcast live from the investor relations sectio
ADMS Ratings Summary
ADMS Quant Ranking